Astria Therapeutics initiated with an Outperform at JMP Securities
JMP Securities analyst Jonathan Wolleben initiated coverage of Astria Therapeutics (ATXS) with an Outperform rating and $26 price target ...
KalVista initiated with an Outperform at JMP Securities
JMP Securities initiated coverage of KalVista (KALV) with an Outperform rating and $19 price target KalVista is developing sebetralstat, a ...
JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
JMP Securities raises Pharvaris stock target to $55
Wolleben's updated price target is a reflection of a revised revenue forecast for Pharvaris's prophylactic treatment, ...
JMP Securities Reiterates “Market Outperform” Rating for Alexandria Real Estate Equities (NYSE:ARE)
Alexandria Real Estate Equities (NYSE:ARE – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by equities researchers at JMP Securities in a report released on Wednesday,Benzinga ...
bovnews14h
What’s Behind the -4.69% Drop in Sana Biotechnology Inc (SANA) Stock? Find Out Now!
Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.25 which represents a decrease of $-0.16 or -4.69% from the prior close of $3.41. The stock opened at $3.4 and touched a low of ...
bovnews19h
Innovid Corp (CTV) Stock: Unveiling Its Hidden Strengths
JMP Securities has recently reduced Innovid Corp (CTV) stock to Mkt Perform rating, as announced on November 21, 2024, according to Finviz. Analyst ratings are significant because they provide ...